You have 6 free searches left this month | for more free features.

Overall Status

Recruiting (11)

Not yet recruiting (6)

Completed (5)

Active, not recruiting (2)

Withdrawn (2)

Enrolling by invitation (1)

Terminated (1)

Sign in for free

Phase

phase 2 (17)

phase 1 (3)

phase 1/phase 2 (2)

phase 3 (2)

early phase 1 (1)

Study Documents

Intervention Type

drug (27)

biological (1)

procedure (1)

radiation (1)

Funder Type

Other (20)

Industry (8)

Study Type

Interventional (25)

Observational (3)

Pamiparib

Showing 26 - 28 of 28

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Neoadjuvant Therapy, High Risk Prostate Cancer, Locally Advanced Prostate Cancer Trial in Nanjing (ADT, Abiraterone Acetate,

Recruiting

Neoadjuvant Therapy
+3 more

ADT
+8 more

Nanjing, Jiangsu, China

Department of Urology, Drum Tower Hospital, Medical School of Na

Aug 12, 2022

Advanced Gastric Cancer Trial in Shanghai (Transcatheter Arterial Chemoembolization, Tislelizumab)

Recruiting

Advanced Gastric Cancer

Transcatheter Arterial Chemoembolization
Tislelizumab

Shanghai, Shanghai, China

ZhongShan hospital Fudan university

May 25, 2022

Advanced Gastroesophageal Adenocarcinoma, First-line Therapy, PDL1 CPS < 5 Trial (CAPOX combined with bevacizumab and

Not yet recruiting

Advanced Gastroesophageal Adenocarcinoma
+2 more

CAPOX combined with bevacizumab and Tislelizumab

(no location specified)

Mar 17, 2022